Ask AI
ProCE Banner Activity

What AIDS 2026 Revealed About the Asia-Pacific Region's Long-Acting PrEP Gap

Conference Coverage
Clinical Thought

Asia and the Pacific Islands account for nearly a quarter of global new HIV infections annually, yet the region utilizes less than 5% of global pre-exposure prophylaxis (PrEP). Keep reading to learn how inadequate translation of scientific progress in long-acting PrEP products into equitable access framed key discussions at the 26th International AIDS Conference (AIDS 2026).

Released: September 01, 2026

Review Activity

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

This activity is supported through independent educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare

Partners

International AIDS Society

ProCE Banner

Target Audience

This activity is intended for physicians, pharmacists, registered nurses, and other healthcare professionals who care for people living with or at risk of HIV infection.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Integrate the latest scientific findings to develop and optimize effective HIV prevention interventions

Financial Disclosures

Primary Author

Nittaya Phanuphak, MD, PhD: researcher: Gilead, MSD, ViiV.